 |
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
 |
||||||||||||||||
|
||||||||||||||||
 |
||||||||||||||||
|
||||||||||||||||
|
|
|
|
Stock data
| Last Trade | 1.729 | Trade Time | 5/24/2013 1:32:00 PM |
| Change |  -0.061
|
Volume (thou) | 51.843 |
| %Change | -3.41% | Last Trade Size | |
| Open | 1.79 | Bid | 1.71 |
| Today's High | 1.79 | Ask | 1.73 |
| Today's Low | 1.71 | Size Bid/Ask | 35 x9 |
Fundamental Data |
|||
| Market Cap (mil) | 47682.36 | 52 Week High | 7.10 |
| Shrs Outstanding (thou) | 27578000 | 52 Week Low | 1.00 |
| EPS | -1.01 | PE Ratio | .00 |
| Volatility | Yield | .00 | |
| Dividend Freq. | 0 | Ex-Dividend Date | 12:00:00 AM |
| Dividend Amount | 0 | Exchange | NASDAQ GM-D |
| Delayed quotes powered by S&P comstock. All stock quotes are delayed by 20 minutes and are believed to be accurate but are not warranted or guaranteed by MENAFN.com | |||
Related News
 |
May 13, 2013 | BG Medicine Inc awards inducement grant at exercise price of USD1.67 as part of NASDAQ Listing Rule 5635(c)(4), M2 |
|
May 10, 2013 | BG Medicine, Inc. Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4), GlobeNewswire |
|
May 10, 2013 | BG Medicine Inc names Dr Paul Sohmer as CEO, M2 |
|
May 09, 2013 | BG Medicine Appoints Dr. Paul Sohmer as Chief Executive Officer, GlobeNewswire |
|
May 09, 2013 | BG Medicine Reports 2013 First Quarter Financial Results, GlobeNewswire |
|
May 08, 2013 | BRIEF: BG Medicine diagnostic tool used by New Jersey group, McClatchy-Tribune Information Services -- Unrestricted |
|
May 08, 2013 | Trenton Health Team Adopts Novel Diagnostic Tool, BGM Galectin-3(R) Test, to Reduce Hospital Readmissions, GlobeNewswire |
|
May 02, 2013 | BG Medicine to Announce First Quarter 2013 Financial Results and Host Conference Call on Thursday, May 9, 2013, GlobeNewswire |
 more... |
||
